Evidence map›Paper›PMID 41105855›Full record

ReviewJornal brasileiro de nefrologia

Glomerulopathy associated with schistosomiasis mansoni.

Irma Bandeira de Sousa Pontes, Amaro Nunes Duarte Neto, Cristiane Bitencourt Dias

Abstract readReview
In one paragraph

Review in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Irma Bandeira de Sousa PontesUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Laboratório de Fisiopatologia Renal, São Paulo, SP, Brazil.ORCID http://orcid.org/0009-0008-8892-0616
Amaro Nunes Duarte NetoUniversidade de São Paulo, Faculdade de Medicina, Departamento de Patologia, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-6659-7186
Cristiane Bitencourt DiasUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Laboratório de Fisiopatologia Renal, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-9800-260X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis is a parasitic disease directly related to poor sanitation. In Brazil, 42 million people live in areas where the disease is endemic, and it is still considered a serious public health problem. The kidney is one of the organs typically affected by this worm, with descriptions of renal tubular alterations, acute kidney injury and glomerular diseases. Among patients with active schistosomiasis, the incidence of glomerulopathy is 5-6% overall and 15% in those with the hepatosplenic form with the most commonly described histological patterns being membranoproliferative glomerulonephritis and focal segmental glomerulosclerosis. Although the pathogenesis of glomerular disease associated with schistosomiasis is uncertain, it is thought to involve immune complexes, especially in membranoproliferative glomerulonephritis, formed against a schistosome antigen and deposited in the glomeruli. The uncertain pathogenesis makes schistosomiasis treatment a challenge, as eradicating the parasite through the use of an anti-parasitic agent does not stop the progression to chronic kidney disease, raising questions about the need for immunosuppressive therapy. Thus, the aim of this review was to describe the so-called classic information on glomerular disease associated with schistosomiasis and to explore its probable pathogenic mechanisms in order to promote future discussion on the development of better treatment options.

Indexed as

GlomerulonephritisSchistosomiasis mansoniHumans

Identifiers

PMID41105855
PMCPMC12534032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.